Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Net Income 2010-2025 | AMGN

Amgen annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending March 31, 2025 was $1.730B, a 1630.97% decline year-over-year.
  • Amgen net income for the twelve months ending March 31, 2025 was $5.933B, a 57.67% increase year-over-year.
  • Amgen annual net income for 2024 was $4.09B, a 39.11% decline from 2023.
  • Amgen annual net income for 2023 was $6.717B, a 2.52% increase from 2022.
  • Amgen annual net income for 2022 was $6.552B, a 11.18% increase from 2021.
  
Amgen Annual Net Income
(Millions of US $)
2024 $4,090
2023 $6,717
2022 $6,552
2021 $5,893
2020 $7,264
2019 $7,842
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
Amgen Quarterly Net Income
(Millions of US $)
2025-03-31 $1,730
2024-12-31 $627
2024-09-30 $2,830
2024-06-30 $746
2024-03-31 $-113
2023-12-31 $767
2023-09-30 $1,730
2023-06-30 $1,379
2023-03-31 $2,841
2022-12-31 $1,616
2022-09-30 $2,143
2022-06-30 $1,317
2022-03-31 $1,476
2021-12-31 $1,899
2021-09-30 $1,884
2021-06-30 $464
2021-03-31 $1,646
2020-12-31 $1,615
2020-09-30 $2,021
2020-06-30 $1,803
2020-03-31 $1,825
2019-12-31 $1,703
2019-09-30 $1,968
2019-06-30 $2,179
2019-03-31 $1,992
2018-12-31 $1,928
2018-09-30 $1,859
2018-06-30 $2,296
2018-03-31 $2,311
2017-12-31 $-4,264
2017-09-30 $2,021
2017-06-30 $2,151
2017-03-31 $2,071
2016-12-31 $1,935
2016-09-30 $2,017
2016-06-30 $1,870
2016-03-31 $1,900
2015-12-31 $1,800
2015-09-30 $1,863
2015-06-30 $1,653
2015-03-31 $1,623
2014-12-31 $1,294
2014-09-30 $1,244
2014-06-30 $1,547
2014-03-31 $1,073
2013-12-31 $1,021
2013-09-30 $1,368
2013-06-30 $1,258
2013-03-31 $1,434
2012-12-31 $788
2012-09-30 $1,107
2012-06-30 $1,266
2012-03-31 $1,184
2011-12-31 $934
2011-09-30 $454
2011-06-30 $1,170
2011-03-31 $1,125
2010-12-31 $1,022
2010-09-30 $1,236
2010-06-30 $1,202
2010-03-31 $1,167
2009-12-31 $931
2009-09-30 $1,386
2009-06-30 $1,269
2009-03-31 $1,019
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $158.768B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $220.597B 16.47
Gilead Sciences (GILD) United States $136.384B 14.17
Vertex Pharmaceuticals (VRTX) United States $120.399B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
GSK (GSK) United Kingdom $78.372B 9.38
CSL (CSLLY) Australia $76.612B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.296B 14.88
Alnylam Pharmaceuticals (ALNY) United States $41.064B 0.00
Argenex SE (ARGX) Netherlands $34.208B 93.37
BioNTech SE (BNTX) Germany $27.138B 0.00
Royalty Pharma (RPRX) United States $20.151B 8.51
Biogen (BIIB) United States $19.666B 8.48
Insmed (INSM) United States $18.626B 0.00
Illumina (ILMN) United States $15.711B 29.80
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.729B 15.40
Incyte (INCY) United States $13.277B 100.87
Moderna (MRNA) United States $13.010B 0.00
Exelixis (EXEL) United States $12.234B 20.77
BioMarin Pharmaceutical (BMRN) United States $11.142B 18.10
QIAGEN (QGEN) Netherlands $10.699B 20.82
Ascendis Pharma (ASND) Denmark $10.696B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $9.792B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.924B 0.00
Bio-Techne Corp (TECH) United States $8.487B 31.66
Blueprint Medicines (BPMC) United States $8.350B 0.00
Roivant Sciences (ROIV) United Kingdom $7.723B 0.00
Repligen (RGEN) United States $7.314B 81.88
Legend Biotech (LEGN) United States $7.159B 0.00
Anbio Biotechnology (NNNN) Germany $7.088B 0.00
Revolution Medicines (RVMD) United States $7.082B 0.00
Halozyme Therapeutics (HALO) United States $7.042B 13.48
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Jazz Pharmaceuticals (JAZZ) Ireland $6.673B 6.55
Guardant Health (GH) United States $6.225B 0.00
TG Therapeutics (TGTX) United States $5.887B 154.52
Nuvalent (NUVL) United States $5.812B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.516B 0.00
Telix Pharmaceuticals (TLX) Australia $5.404B 0.00
Axsome Therapeutics (AXSM) United States $5.366B 0.00
Alkermes (ALKS) Ireland $4.993B 13.40
CRISPR Therapeutics AG (CRSP) Switzerland $4.905B 0.00
Vaxcyte (PCVX) United States $4.635B 0.00
Cytokinetics (CYTK) United States $4.420B 0.00
ADMA Biologics Inc (ADMA) United States $4.419B 33.05
Krystal Biotech (KRYS) United States $4.282B 33.00
Metsera (MTSR) United States $4.127B 0.00
Akero Therapeutics (AKRO) United States $4.111B 0.00
Zealand Pharma (ZLDPF) Denmark $4.088B 0.00
PTC Therapeutics (PTCT) United States $3.848B 6.70
Arcellx (ACLX) United States $3.801B 0.00
Avidity Biosciences (RNA) United States $3.790B 0.00
Merus (MRUS) Netherlands $3.772B 0.00
Zai Lab (ZLAB) China $3.636B 0.00
Scholar Rock Holding (SRRK) United States $3.555B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.511B 30.85
Viking Therapeutics (VKTX) United States $3.494B 0.00
Ascentage Pharma Group - (AAPG) China $3.331B 0.00
Protagonist Therapeutics (PTGX) United States $3.285B 70.67
MoonLake Immunotherapeutics (MLTX) Switzerland $3.137B 0.00
Immunovant (IMVT) United States $3.101B 0.00
Kymera Therapeutics (KYMR) United States $2.897B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.796B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.790B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.609B 0.00
Alvotech (ALVO) Luxembourg $2.569B 14.69
Arrowhead Pharmaceuticals (ARWR) United States $2.529B 0.00
ImmunityBio (IBRX) United States $2.480B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.472B 0.00
Apellis Pharmaceuticals (APLS) United States $2.443B 0.00
Ligand Pharmaceuticals (LGND) United States $2.348B 0.00
Twist Bioscience (TWST) United States $2.279B 0.00
Agios Pharmaceuticals (AGIO) United States $2.262B 0.00
Bavarian Nordic (BVNRY) Denmark $2.236B 11.81
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
Beam Therapeutics (BEAM) United States $2.128B 0.00
Denali Therapeutics (DNLI) United States $2.109B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.050B 0.00
CG Oncology (CGON) United States $2.037B 0.00
Belite Bio (BLTE) United States $2.013B 0.00
Vericel (VCEL) United States $2.010B 1331.00
Disc Medicine (IRON) United States $1.971B 0.00
IDEAYA Biosciences (IDYA) United States $1.969B 0.00
NovoCure (NVCR) Jersey $1.962B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.952B 12.98
Amicus Therapeutics (FOLD) United States $1.875B 203.00
Certara (CERT) United States $1.799B 33.61
Adaptive Biotechnologies (ADPT) United States $1.796B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.789B 0.00
Sarepta Therapeutics (SRPT) United States $1.786B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.759B 0.00
Apogee Therapeutics (APGE) United States $1.756B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.646B 0.00
89BIO (ETNB) United States $1.606B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Vera Therapeutics (VERA) United States $1.519B 0.00
Janux Therapeutics (JANX) United States $1.488B 0.00
GRAIL (GRAL) United States $1.465B 0.00
Travere Therapeutics (TVTX) United States $1.463B 0.00
Edgewise Therapeutics (EWTX) United States $1.456B 0.00
Biohaven (BHVN) United States $1.422B 0.00
Mesoblast (MESO) Australia $1.420B 0.00
ANI Pharmaceuticals (ANIP) United States $1.407B 14.50
Viridian Therapeutics (VRDN) United States $1.390B 0.00
Pharvaris (PHVS) Netherlands $1.314B 0.00
Dynavax Technologies (DVAX) United States $1.270B 75.57
Cogent Biosciences (COGT) United States $1.250B 0.00
CureVac (CVAC) Germany $1.225B 5.93
Liquidia Technologies (LQDA) United States $1.204B 0.00
WAVE Life Sciences (WVE) Singapore $1.198B 0.00
AbCellera Biologics (ABCL) Canada $1.197B 0.00
Intellia Therapeutics (NTLA) United States $1.195B 0.00
MannKind (MNKD) United States $1.146B 23.56
Novavax (NVAX) United States $1.108B 2.58
Structure Therapeutics (GPCR) United States $1.090B 0.00
Pacira BioSciences (PCRX) United States $1.060B 10.09
Praxis Precision Medicines (PRAX) United States $1.029B 0.00
Cidara Therapeutics (CDTX) United States $1.019B 0.00
Arcus Biosciences (RCUS) United States $0.988B 0.00
MiMedx (MDXG) United States $0.984B 23.79
LENZ Therapeutics (LENZ) United States $0.976B 0.00
Nurix Therapeutics (NRIX) United States $0.951B 0.00
Anavex Life Sciences (AVXL) United States $0.948B 0.00
Oric Pharmaceuticals (ORIC) United States $0.946B 0.00
Spyre Therapeutics (SYRE) United States $0.946B 0.00
Mineralys Therapeutics (MLYS) United States $0.944B 0.00
Sana Biotechnology (SANA) United States $0.942B 0.00
NeoGenomics (NEO) United States $0.934B 0.00
Zymeworks (ZYME) United States $0.930B 0.00
BGM Group (BGM) China $0.905B 0.00
Sionna Therapeutics (SION) United States $0.901B 0.00
Niagen Bioscience (NAGE) United States $0.890B 125.56
Replimune (REPL) United States $0.846B 0.00
Geron (GERN) United States $0.841B 0.00
GH Research (GHRS) Ireland $0.826B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.825B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.789B 0.00
Oculis Holding AG (OCS) Switzerland $0.789B 0.00
Vir Biotechnology (VIR) United States $0.781B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Trevi Therapeutics (TRVI) United States $0.768B 0.00
Jyong Biotech (MENS) Taiwan $0.761B 0.00
CorMedix Inc (CRMD) United States $0.761B 51.00
Immunome (IMNM) United States $0.752B 0.00
Nuvation Bio (NUVB) United States $0.749B 0.00
ArriVent BioPharma (AVBP) United States $0.740B 0.00
Immatics (IMTX) Germany $0.726B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.713B 0.00
Gyre Therapeutics (GYRE) United States $0.702B 187.25
Day One Biopharmaceuticals (DAWN) United States $0.688B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Pharming Group (PHAR) Netherlands $0.680B 0.00
Maze Therapeutics (MAZE) United States $0.659B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.657B 0.00
Urogen Pharma (URGN) United States $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.648B 15.01
Dianthus Therapeutics (DNTH) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Tango Therapeutics (TNGX) United States $0.643B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.641B 0.00
Iovance Biotherapeutics (IOVA) United States $0.624B 0.00
Upstream Bio (UPB) United States $0.618B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.609B 0.00
Arbutus Biopharma (ABUS) United States $0.607B 0.00
Keros Therapeutics (KROS) United States $0.586B 0.00
Prime Medicine (PRME) United States $0.585B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.584B 0.00
Sage Therapeutics (SAGE) United States $0.581B 0.00
Arvinas (ARVN) United States $0.569B 0.00
Castle Biosciences (CSTL) United States $0.568B 38.55
Bicycle Therapeutics (BCYC) United Kingdom $0.554B 0.00
Tyra Biosciences (TYRA) United States $0.545B 0.00
Kura Oncology (KURA) United States $0.544B 0.00
Precigen (PGEN) United States $0.540B 0.00
Rapport Therapeutics (RAPP) United States $0.533B 0.00
Bicara Therapeutics (BCAX) United States $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
Abivax SA (ABVX) France $0.525B 0.00
Septerna (SEPN) United States $0.523B 0.00
Celcuity (CELC) United States $0.516B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
Myriad Genetics (MYGN) United States $0.492B 0.00
ATyr Pharma (ATYR) United States $0.472B 0.00
Zenas BioPharma (ZBIO) United States $0.468B 0.00
Fortrea Holdings (FTRE) United States $0.462B 12.78
Cullinan Therapeutics (CGEM) United States $0.454B 0.00
Rezolute (RZLT) United States $0.450B 0.00
Kamada (KMDA) Israel $0.446B 26.72
Cytek Biosciences (CTKB) United States $0.437B 0.00
MBX Biosciences (MBX) United States $0.436B 0.00
REGENXBIO (RGNX) United States $0.435B 0.00
Terns Pharmaceuticals (TERN) United States $0.428B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Fulcrum Therapeutics (FULC) United States $0.423B 0.00
Tectonic Therapeutic (TECX) United States $0.423B 0.00
Erasca (ERAS) United States $0.411B 0.00
Solid Biosciences (SLDB) United States $0.408B 0.00
Emergent Biosolutions (EBS) United States $0.399B 0.00
ITeos Therapeutics (ITOS) United States $0.394B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.390B 0.00
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.374B 0.00
Compass Therapeutics (CMPX) United States $0.373B 0.00
Astria Therapeutics (ATXS) United States $0.359B 0.00
Humacyte (HUMA) United States $0.358B 0.00
Amarin (AMRN) Ireland $0.351B 0.00
Cartesian Therapeutics (RNAC) United States $0.346B 0.00
Prothena (PRTA) Ireland $0.344B 0.00
Absci (ABSI) United States $0.341B 0.00
Benitec Biopharma (BNTC) United States $0.335B 0.00
Ocugen (OCGN) United States $0.333B 0.00
Northwest Biotherapeutics (NWBO) United States $0.332B 0.00
XOMA Royalty (XOMA) United States $0.325B 0.00
Aura Biosciences (AURA) United States $0.322B 0.00
Inventiva S.A (IVA) France $0.320B 0.00
Olema Pharmaceuticals (OLMA) United States $0.318B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.317B 64.50
Rocket Pharmaceuticals (RCKT) United States $0.316B 0.00
Inhibrx Biosciences (INBX) United States $0.315B 0.19
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Vor Biopharma (VOR) $0.312B 0.00
Gossamer Bio (GOSS) United States $0.309B 0.00
Lifecore Biomedical (LFCR) United States $0.307B 0.00
Neurogene (NGNE) United States $0.306B 0.00
Foghorn Therapeutics (FHTX) United States $0.301B 0.00
DBV Technologies S.A (DBVT) France $0.296B 0.00
Abeona Therapeutics (ABEO) United States $0.294B 0.00
Palvella Therapeutics (PVLA) United States $0.293B 0.00
Candel Therapeutics (CADL) United States $0.291B 0.00
Sagimet Biosciences (SGMT) United States $0.290B 0.00
Annexon (ANNX) United States $0.283B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.282B 0.00
Allogene Therapeutics (ALLO) United States $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Aardvark Therapeutics (AARD) United States $0.264B 0.00
Verastem (VSTM) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.257B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.256B 0.00
Tvardi Therapeutics (TVRD) United States $0.256B 0.00
MiNK Therapeutics (INKT) United States $0.256B 0.00
Crescent Biopharma (CBIO) United States $0.253B 0.00
Entrada Therapeutics (TRDA) United States $0.249B 8.09
Codexis (CDXS) United States $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
Adherex Technologies (FENC) United States $0.242B 0.00
Editas Medicine (EDIT) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Kodiak Sciences (KOD) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.236B 0.00
ScPharmaceuticals (SCPH) United States $0.231B 0.00
Monopar Therapeutics (MNPR) United States $0.225B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Semper Paratus Acquisition (TVGN) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
BioStem Technologies (BSEM) $0.210B 8.52
Neumora Therapeutics (NMRA) United States $0.209B 0.00
AC Immune (ACIU) Switzerland $0.205B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.205B 0.00
Citius Oncology (CTOR) United States $0.202B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
CytomX Therapeutics (CTMX) United States $0.195B 5.04
Ventyx Biosciences (VTYX) United States $0.195B 0.00
Agenus (AGEN) United States $0.194B 0.00
Voyager Therapeutics (VYGR) United States $0.193B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.193B 0.00
Alumis (ALMS) United States $0.192B 0.00
SELLAS Life Sciences (SLS) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Kyverna Therapeutics (KYTX) United States $0.174B 0.00
I-Mab (IMAB) United States $0.174B 0.00
Alpha Cognition (ACOG) Canada $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.173B 0.00
EnGene Holdings (ENGN) Canada $0.169B 0.00
Puma Biotechnology (PBYI) United States $0.168B 4.40
Nuvectis Pharma (NVCT) United States $0.165B 0.00
BioAge Labs (BIOA) United States $0.163B 0.00
Black Diamond Therapeutics (BDTX) United States $0.163B 47.83
Anika Therapeutics (ANIK) United States $0.162B 0.00
Alector (ALEC) United States $0.161B 0.00
Innate Pharma S.A (IPHA) France $0.161B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Immuneering (IMRX) United States $0.159B 0.00
C4 Therapeutics (CCCC) United States $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.153B 0.00
Caribou Biosciences (CRBU) United States $0.152B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Greenwich LifeSciences (GLSI) United States $0.145B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.140B 0.00
Rapt Therapeutics (RAPT) United States $0.140B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Fate Therapeutics (FATE) United States $0.132B 0.00
Nkarta (NKTX) United States $0.130B 0.00
Genelux (GNLX) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
Seer (SEER) United States $0.124B 0.00
Skye Bioscience (SKYE) United States $0.123B 0.00
Actuate Therapeutics (ACTU) United States $0.120B 0.00
BioHarvest Sciences (BHST) Canada $0.118B 0.00
Sangamo Therapeutics (SGMO) United States $0.115B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.112B 0.00
Oncolytics Biotech (ONCY) Canada $0.111B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Contineum Therapeutics (CTNM) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Elutia (ELUT) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
OKYO Pharma (OKYO) $0.095B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Adagene (ADAG) China $0.090B 0.00
Whitehawk Therapeutics (WHWK) United States $0.090B 0.00
Zura Bio (ZURA) United States $0.090B 0.00
Invivyd (IVVD) United States $0.089B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Cabaletta Bio (CABA) United States $0.088B 0.00
Pliant Therapeutics (PLRX) United States $0.087B 0.00
XBiotech (XBIT) United States $0.086B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.085B 0.00
Connect Biopharma Holdings (CNTB) United States $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Quince Therapeutics (QNCX) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Entera Bio (ENTX) Israel $0.079B 0.00
Biomea Fusion (BMEA) United States $0.075B 0.00
Immix Biopharma (IMMX) United States $0.074B 0.00
Genenta Science S.p.A (GNTA) Italy $0.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Oncobiologics (OTLK) United States $0.069B 0.00
Forte Biosciences (FBRX) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.069B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.064B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
MediciNova (MNOV) United States $0.062B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.059B 0.00
Cue Biopharma (CUE) United States $0.058B 0.00
PDS Biotechnology (PDSB) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
INmune Bio (INMB) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Quantum Biopharma (QNTM) Canada $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Jasper Therapeutics (JSPR) United States $0.053B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Aligos Therapeutics (ALGS) United States $0.051B 0.00
Celularity (CELU) United States $0.051B 0.00
Inovio Pharmaceuticals (INO) United States $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Grace Therapeutics (GRCE) Canada $0.048B 0.00
RenovoRx (RNXT) United States $0.047B 0.00
Renovaro (RENB) United States $0.046B 0.00
Exicure (XCUR) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Hyperion DeFi (HYPD) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
KALA BIO (KALA) United States $0.038B 0.00
Rani Therapeutics Holdings (RANI) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Cognition Therapeutics (CGTX) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Q32 Bio (QTTB) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Clene (CLNN) United States $0.030B 0.00
Ovid Therapeutics (OVID) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
CalciMedica (CALC) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Passage Bio (PASG) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
IBio (IBIO) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Artelo Biosciences (ARTL) United States $0.013B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Cyclerion Therapeutics (CYCN) United States $0.012B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
NextCure (NXTC) United States $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
X4 Pharmaceuticals (XFOR) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
LakeShore Biopharma (LSB) China $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00